Leukemia & Lymphoma, Volume 52, Issue 7 (2011)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 52, Issue 7 (2011)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Volume 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentary

Article Commentary
Minimal residual disease: the advantages of digital over analog polymerase chain reaction
David M. Ross & Susan Branford
Pages: 1161-1163
Published online: 25 May 2011
First Page PreviewforMinimal residual disease: the advantages of digital over analog polymerase chain reaction | Full Text | References | PDF (123.3 KB) | Supplemental
  • 983 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Optimal central nervous system prophylaxis in Philadelphia chromosome-positive acute lymphoblastic leukemia: collateral damage in the imatinib era?
Renato Bassan
Pages: 1164-1165
Published online: 25 May 2011
CitationforOptimal central nervous system prophylaxis in Philadelphia chromosome-positive acute lymphoblastic leukemia: collateral damage in the imatinib era? | Full Text | References | PDF (117.4 KB) | Supplemental
  • 692 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Getting to the heart of the problem in treating diffuse large B-cell lymphoma
Paul M. Barr & Jonathan W. Friedberg
Pages: 1166-1167
Published online: 25 May 2011
CitationforGetting to the heart of the problem in treating diffuse large B-cell lymphoma | Full Text | References | PDF (116.5 KB) | Supplemental
  • 1167 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Endogenous interferon α therapy in follicular lymphoma?
Karoline Koch & Wolfram Klapper
Pages: 1168-1169
Published online: 23 Jun 2011
CitationforEndogenous interferon α therapy in follicular lymphoma? | Full Text | References | PDF (117.2 KB)
  • 381 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Predicting outcomes in multiple myeloma: do we really need another model?
David H. Vesole
Pages: 1170-1172
Published online: 23 Jun 2011
First Page PreviewforPredicting outcomes in multiple myeloma: do we really need another model? | Full Text | References | PDF (120.5 KB) | Supplemental
  • 645 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Angiogenesis and multiple myeloma: is there a role for angiogenic biomarkers in the context of autologous stem cell transplant?
Kenneth S. Cohen
Pages: 1173-1175
Published online: 23 Jun 2011
First Page PreviewforAngiogenesis and multiple myeloma: is there a role for angiogenic biomarkers in the context of autologous stem cell transplant? | Full Text | References | PDF (55.6 KB) | Supplemental
  • 509 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Localization of death receptor 4 in lipid rafts sensitizes chronic lymphocytic leukemia to chemotherapeutic drug mediated apoptosis
Shahab Uddin & Khawla S. Al-Kuraya
Pages: 1176-1177
Published online: 04 Apr 2011
CitationforLocalization of death receptor 4 in lipid rafts sensitizes chronic lymphocytic leukemia to chemotherapeutic drug mediated apoptosis | Full Text | References | PDF (48.5 KB) | Supplemental
  • 459 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Reviews

Review Article
Myeloproliferative neoplasms 5 years after discovery of JAK2V617F: what is the impact of JAK2 inhibitor therapy?
Raoul Tibes & Ruben A. Mesa
Pages: 1178-1187
Published online: 23 May 2011
AbstractforMyeloproliferative neoplasms 5 years after discovery of JAK2V617F: what is the impact of JAK2 inhibitor therapy? | Full Text | References | PDF (172.8 KB) | Supplemental
  • 596 Views
  • 12 CrossRef citations
  • 0Altmetric
Review Article
Treatment recommendations for radioimmunotherapy in follicular lymphoma: a consensus conference report
Thomas E. Witzig, Paul Fishkin, Leo I. Gordon, Stephanie A. Gregory, Samuel Jacobs, Roger Macklis, Peter Mclaughlin, Oliver Press & Andrew D. Zelenetz
Pages: 1188-1199
Published online: 23 May 2011
AbstractforTreatment recommendations for radioimmunotherapy in follicular lymphoma: a consensus conference report | Full Text | References | PDF (699.6 KB) | Supplemental
  • 755 Views
  • 31 CrossRef citations
  • 0Altmetric
Review Article
NOTCH and phosphatidylinositide 3-kinase/phosphatase and tensin homolog deleted on chromosome ten/AKT/mammalian target of rapamycin (mTOR) signaling in T-cell development and T-cell acute lymphoblastic leukemia
Dongmei Guo, Qingliang Teng & Chunyan Ji
Pages: 1200-1210
Published online: 04 Apr 2011
AbstractforNOTCH and phosphatidylinositide 3-kinase/phosphatase and tensin homolog deleted on chromosome ten/AKT/mammalian target of rapamycin (mTOR) signaling in T-cell development and T-cell acute lymphoblastic leukemia | Full Text | References | PDF (237.7 KB) | Supplemental
  • 669 Views
  • 24 CrossRef citations
  • 0Altmetric

Original Articles: Clinical

Article
Subdural hematomas in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving imatinib mesylate in conjunction with systemic and intrathecal chemotherapy
Shiven B. Patel, Ivana Gojo, Michael L. Tidwell, Edward A. Sausville & Maria R. Baer
Pages: 1211-1214
Published online: 03 May 2011
AbstractforSubdural hematomas in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving imatinib mesylate in conjunction with systemic and intrathecal chemotherapy | Full Text | References | PDF (131.4 KB) | Supplemental
  • 374 Views
  • 23 CrossRef citations
  • 0Altmetric
Article
Prognostic impact of t(1;19)/ TCF3–PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin–Frankfurt–Münster-based protocols
MarÍa S. Felice, Marta S. Gallego, Cristina N. Alonso, Elizabeth M. Alfaro, Myriam R. Guitter, Andrea R. Bernasconi, Patricia L. Rubio, Pedro A. Zubizarreta & Jorge G. Rossi
Pages: 1215-1221
Published online: 03 May 2011
AbstractforPrognostic impact of t(1;19)/ TCF3–PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin–Frankfurt–Münster-based protocols | Full Text | References | PDF (238.3 KB) | Supplemental
  • 713 Views
  • 47 CrossRef citations
  • 0Altmetric
Article
Non-pegylated liposomal doxorubicin (Myocet®) in patients with poor-risk aggressive B-cell non-Hodgkin lymphoma
Matteo Dell'olio, Rosario Potito scalzulli, Grazia Sanpaolo, Michele Nobile, Francesco Saverio mantuano, Antonio La sala, Giovanni D'arena, Eustachio Miraglia, Anna Lucania, Lucia Mastrullo & Cascavilla Nicola
Pages: 1222-1229
Published online: 25 May 2011
AbstractforNon-pegylated liposomal doxorubicin (Myocet®) in patients with poor-risk aggressive B-cell non-Hodgkin lymphoma | Full Text | References | PDF (215.8 KB) | Supplemental
  • 349 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
Intratumoral plasmacytoid dendritic cells associate with increased survival in patients with follicular lymphoma
Raphael Butsch, Stephan Lukas waelti, Sarah Schaerer, Julia Braun, Dimitri Korol, Nicole Probst-hensch, Holger Moch & Michael Kurrer
Pages: 1230-1238
Published online: 23 May 2011
AbstractforIntratumoral plasmacytoid dendritic cells associate with increased survival in patients with follicular lymphoma | Full Text | References | PDF (526.4 KB) | Supplemental
  • 182 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
Quality of life in 269 patients with poor-risk diffuse large B-cell lymphoma treated with rituximab versus observation after autologous stem cell transplant
Natacha Heutte, Corinne Haioun, Pierre Feugier, Bertrand Coiffier, Herve Tilly, Christophe Ferme, Jean Gabarre, Franck Morschhauser, Christian Gisselbrecht, Nicolas Mounier & For the Groupe D'etude Des Lymphomes De L'adulte
Pages: 1239-1248
Published online: 04 Apr 2011
AbstractforQuality of life in 269 patients with poor-risk diffuse large B-cell lymphoma treated with rituximab versus observation after autologous stem cell transplant | Full Text | References | PDF (579.5 KB) | Supplemental
  • 551 Views
  • 13 CrossRef citations
  • 0Altmetric
Article
An XRCC1 polymorphism is associated with the outcome of patients with lymphoma undergoing autologous stem cell transplant
Vicent M. Guillem, Cristina Arbona, Juan Carlos Hernández-Boluda, María José Terol, Rosa Goterris, Carlos Solano & Mar Tormo
Pages: 1249-1254
Published online: 04 Apr 2011
AbstractforAn XRCC1 polymorphism is associated with the outcome of patients with lymphoma undergoing autologous stem cell transplant | Full Text | References | PDF (226.8 KB) | Supplemental
  • 129 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Allogeneic hematopoietic stem cell transplantation for advanced extranodal natural killer/T-cell lymphoma, nasal type
Daisuke Ennishi, Yoshinobu Maeda, Nobuharu Fujii, Eisei Kondo, Katsuji Shinagawa, Kazuma Ikeda, Koichi Ichimura, Tadashi Yoshino & Mitsune Tanimoto
Pages: 1255-1261
Published online: 23 May 2011
AbstractforAllogeneic hematopoietic stem cell transplantation for advanced extranodal natural killer/T-cell lymphoma, nasal type | Full Text | References | PDF (346.8 KB) | Supplemental
  • 650 Views
  • 39 CrossRef citations
  • 0Altmetric
Article
Lenalidomide can induce long-term responses in patients with multiple myeloma relapsing after multiple chemotherapy lines, in particular after allogeneic transplant
Francesco Spina, Vittorio Montefusco, Claudia Crippa, Annalisa Citro, Simona Sammassimo, Barbara Olivero, Silvia Gentili, Monica Galli, Tommasina Guglielmelli, Davide Rossi, Antonietta Pia falcone, Mariella Grasso, Francesca Patriarca, Marianna De muro & Paolo Corradini
Pages: 1262-1270
Published online: 03 May 2011
AbstractforLenalidomide can induce long-term responses in patients with multiple myeloma relapsing after multiple chemotherapy lines, in particular after allogeneic transplant | Full Text | References | PDF (367.7 KB) | Supplemental
  • 474 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Superior overall survival of patients with myeloma achieving very good partial response or better to initial treatment with bortezomib, pegylated liposomal doxorubicin, and dexamethasone, predicted after two cycles by a free light chain- and M-protein-based model: extended follow-up of a phase II trial
Dominik Dytfeld, Kent A. Griffith, Judah Friedman, Daniel Lebovic, Colleen Harvey, Mark S. Kaminski & Andrzej J. Jakubowiak
Pages: 1271-1280
Published online: 23 Jun 2011
AbstractforSuperior overall survival of patients with myeloma achieving very good partial response or better to initial treatment with bortezomib, pegylated liposomal doxorubicin, and dexamethasone, predicted after two cycles by a free light chain- and M-protein-based model: extended follow-up of a phase II trial | Full Text | References | PDF (561.7 KB)
  • 384 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
Prognostic value of bone marrow microvessel density and angiogenic cytokines in patients with multiple myeloma undergoing autologous stem cell transplant
Gülsan Türköz Sucak, Şahika Zeynep Aki, Bilgehan YüzbaşioĞlu, Nalân Akyürek, Münci YaĞci, Ümit BaĞriaçik & Rauf Haznedar
Pages: 1281-1289
Published online: 23 May 2011
AbstractforPrognostic value of bone marrow microvessel density and angiogenic cytokines in patients with multiple myeloma undergoing autologous stem cell transplant | Full Text | References | PDF (580.4 KB) | Supplemental
  • 214 Views
  • 6 CrossRef citations
  • 0Altmetric

Original Articles: Research

Article
Death receptor 4 is preferentially recruited to lipid rafts in chronic lymphocytic leukemia cells contributing to tumor necrosis related apoptosis inducing ligand-induced synergistic apoptotic responses
Wenyan Xiao, Ganchimeg Ishdorj, Jinmei Sun, James B. Johnston & Spencer B. Gibson
Pages: 1290-1301
Published online: 23 Jun 2011
AbstractforDeath receptor 4 is preferentially recruited to lipid rafts in chronic lymphocytic leukemia cells contributing to tumor necrosis related apoptosis inducing ligand-induced synergistic apoptotic responses | Full Text | References | PDF (1.2 MB) | Supplemental
  • 269 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
Enhanced invasiveness in multidrug resistant leukemic cells is associated with overexpression of P-glycoprotein and cellular inhibitor of apoptosis protein
Meng Hu, Yanping Liu, Chaohua Deng, Rongfei Han, Yanhan Jia, Shengwu Liu, Zhengming Jiang, Xiaochun Cao, Liang He & Qiuping Zhang
Pages: 1302-1311
Published online: 23 May 2011
AbstractforEnhanced invasiveness in multidrug resistant leukemic cells is associated with overexpression of P-glycoprotein and cellular inhibitor of apoptosis protein | Full Text | References | PDF (2.4 MB) | Supplemental
  • 198 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
A novel bisindolymaleimide derivative (WK234) inhibits proliferation and induces apoptosis through the protein kinase Cβ pathway, in chronic myelogenous leukemia K562 cells
Xiang-yan Li, Yan Li, Yi Zhang, Ke Wang, Xia Yuan, Jing Jin, Yan Zhang, Zhan-zhu Liu & Xiao-guang Chen
Pages: 1312-1320
Published online: 03 May 2011
AbstractforA novel bisindolymaleimide derivative (WK234) inhibits proliferation and induces apoptosis through the protein kinase Cβ pathway, in chronic myelogenous leukemia K562 cells | Full Text | References | PDF (740.5 KB) | Supplemental
  • 146 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Refining tumor-associated aneuploidy through ‘genomic recoding’ of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas
Rachael Thomas, Eric L. Seiser, Alison Motsinger-Reif, Luke Borst, Victor E. Valli, Kathryn Kelley, Steven E. Suter, David Argyle, Kristine Burgess, Jerold Bell, Kerstin Lindblad-toh, Jaime F. Modiano & Matthew Breen
Pages: 1321-1335
Published online: 07 Mar 2011
AbstractforRefining tumor-associated aneuploidy through ‘genomic recoding’ of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas | Full Text | References | PDF (1.6 MB) | Supplemental
  • 457 Views
  • 79 CrossRef citations
  • 0Altmetric
Article
PU.1-dependent regulation of UCH L1 expression in B-lymphoma cells
Anjali Bheda, Wei Yue, Anuradha Gullapalli, Julia Shackelford & Joseph S. Pagano
Pages: 1336-1347
Published online: 20 Apr 2011
AbstractforPU.1-dependent regulation of UCH L1 expression in B-lymphoma cells | Full Text | References | PDF (698.6 KB) | Supplemental
  • 201 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
Activation of Paired-homeobox gene PITX1 by del(5)(q31) in T-cell acute lymphoblastic leukemia
Stefan Nagel, Letizia Venturini, Grzegorz K. Przybylski, Piotr Grabarczyk, Björn Schneider, Corinna Meyer, Maren Kaufmann, Christian A. Schmidt, Michaela Scherr, Hans G. Drexler & Roderick A. F. Macleod
Pages: 1348-1359
Published online: 22 Mar 2011
AbstractforActivation of Paired-homeobox gene PITX1 by del(5)(q31) in T-cell acute lymphoblastic leukemia | Full Text | References | PDF (1.5 MB) | Supplemental
  • 364 Views
  • 22 CrossRef citations
  • 0Altmetric

Letter to the Editors

Letter
Significance of soluble interleukin-2 receptor in patients with hemophagocytic lymphohistiocytosis
Lijuan Zhang, Sujiang Zhang, Ji Xu, Yixin Hu, Lingling Wang, Xiaoyan Zhang, Wei Xu, Peng Liu, Hongxia Qiu & Jianyong Li
Pages: 1360-1362
Published online: 22 Mar 2011
First Page PreviewforSignificance of soluble interleukin-2 receptor in patients with hemophagocytic lymphohistiocytosis | Full Text | References | PDF (187 KB) | Supplemental
  • 214 Views
  • 9 CrossRef citations
  • 0Altmetric
Letter
High-dose chemotherapy with busulfan and cyclophosphamide and autologous stem cell rescue in patients with Hodgkin lymphoma
Andrew A. Lane, Steven L. Mcafee, Joanne Kennedy, Christine Dube, Eyal C. Attar, Karen K. Ballen, Bimalangshu R. Dey, Thomas R. Spitzer & Yi-Bin Chen
Pages: 1363-1366
Published online: 25 May 2011
First Page PreviewforHigh-dose chemotherapy with busulfan and cyclophosphamide and autologous stem cell rescue in patients with Hodgkin lymphoma | Full Text | References | PDF (165.3 KB) | Supplemental
  • 134 Views
  • 9 CrossRef citations
  • 0Altmetric
Letter
A case of resistant pediatric histiocytic sarcoma successfully treated with chemo-radiotherapy and autologous peripheral blood stem cell transplant
Chiara Mainardi, Emanuele S. G. D'Amore, Marta Pillon, Tiziana Toffolutti & Angelo Rosolen
Pages: 1367-1371
Published online: 22 Mar 2011
First Page PreviewforA case of resistant pediatric histiocytic sarcoma successfully treated with chemo-radiotherapy and autologous peripheral blood stem cell transplant | Full Text | References | PDF (521.5 KB) | Supplemental
  • 560 Views
  • 12 CrossRef citations
  • 0Altmetric
Letter
Isodicentric duplication of Philadelphia chromosome as a mechanism of resistance to dasatinib in a patient with chronic myeloid leukemia after resistance to imatinib
Giuseppina Loglisci, Massimo Breccia, Mauro Nanni, Marco Mancini, Rosa De Cuia, Laura Cannella, Adriano Salaroli, Vincenzo Federico, Alessandra Serrao, Maria Giovanna loglisci, Michelina Santopietro & Giuliana Alimena
Pages: 1372-1375
Published online: 04 Apr 2011
First Page PreviewforIsodicentric duplication of Philadelphia chromosome as a mechanism of resistance to dasatinib in a patient with chronic myeloid leukemia after resistance to imatinib | Full Text | References | PDF (305.7 KB)
  • 139 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Successful treatment with dasatinib and allogeneic peripheral blood stem cell transplant for imatinib-resistant Philadelphia chromosome-positive acute lymphoblastic leukemia relapsing after bone marrow transplant and donor lymphocyte infusion
Takayoshi Tachibana, Ayumi Numata, Masatsugu Tanaka, Kenji Motohashi, Shin Fujisawa, Hiroyuki Fujita, Rika Sakai, Naoto Tomita, Atsuo Maruta, Yoshiaki Ishigatsubo & Heiwa Kanamori
Pages: 1376-1379
Published online: 25 Mar 2011
First Page PreviewforSuccessful treatment with dasatinib and allogeneic peripheral blood stem cell transplant for imatinib-resistant Philadelphia chromosome-positive acute lymphoblastic leukemia relapsing after bone marrow transplant and donor lymphocyte infusion | Full Text | References | PDF (277.6 KB) | Supplemental
  • 227 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter
Chronic myeloid leukemia with p210 BCR–ABL and monocytosis
Jasmita Dass, Sonal Jain, Seema Tyagi & Sudha Sazawal
Pages: 1380-1381
Published online: 22 Mar 2011
CitationforChronic myeloid leukemia with p210 BCR–ABL and monocytosis | Full Text | References | PDF (163.6 KB) | Supplemental
  • 164 Views
  • 4 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter
Multicenter study of comparative outcomes of hematopoietic stem cell transplant for peripheral T cell lymphoma and natural killer/T-cell lymphoma
William Y. K. Hwang, Liang Piu Koh, Soon-thye Lim, Yeh Ching Linn, Yvonne S. Loh, Mickey B. C. Koh, Colin Phipps Diong, Jing Jing Lee, Xue Hui Zhang, Dimple Rajgor, Mihir Gandhi, Anand Shah & Yeow Tee Goh
Pages: 1382-1386
Published online: 23 May 2011
First Page PreviewforMulticenter study of comparative outcomes of hematopoietic stem cell transplant for peripheral T cell lymphoma and natural killer/T-cell lymphoma | Full Text | References | PDF (195.2 KB) | Supplemental
  • 326 Views
  • 12 CrossRef citations
  • 0Altmetric

Letter to the Editors

Letter
1q triplication as sole cytogenetic abnormality in myelodysplastic syndrome
Jung-Sook Ha & Mi-Sun Choi
Pages: 1387-1389
Published online: 23 May 2011
First Page Previewfor1q triplication as sole cytogenetic abnormality in myelodysplastic syndrome | Full Text | References | PDF (373.8 KB) | Supplemental
  • 103 Views
  • 3 CrossRef citations
  • 0Altmetric

Introduction

Highlights of the 5th Young Investigators' Meeting on chronic lymphocytic leukemia
Kirsten Fischer, Tait Shanafelt & Arnon P. Kater
Pages: 1391-1393
Published online: 23 Jun 2011
First Page PreviewforHighlights of the 5th Young Investigators' Meeting on chronic lymphocytic leukemia | Full Text | PDF (635.5 KB) | Supplemental
  • 111 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Patients with early stage chronic lymphocytic leukemia: new risk stratification based on molecular profiling
Darko Antic, Biljana Mihaljevic, Vladan Cokic, Marija Dencic Fekete, Teodora Karan Djurasevic, Sonja Pavlovic, Natasa Milic & Ivo Elezovic
Pages: 1394-1397
Published online: 23 Jun 2011
AbstractforPatients with early stage chronic lymphocytic leukemia: new risk stratification based on molecular profiling | Full Text | References | PDF (214 KB) | Supplemental
  • 184 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Immunoglobulin class switch recombination in chronic lymphocytic leukemia
Mark C. Lanasa & J. Brice Weinberg
Pages: 1398-1400
Published online: 23 Jun 2011
AbstractforImmunoglobulin class switch recombination in chronic lymphocytic leukemia | Full Text | References | PDF (129.5 KB) | Supplemental
  • 520 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Rituximab–cyclophosphamide–dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemia
Anne-Sophie Michallet, Julien Rossignol, Bruno Cazin & Loic Ysebaert
Pages: 1401-1403
Published online: 23 Jun 2011
AbstractforRituximab–cyclophosphamide–dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemia | Full Text | References | PDF (115.8 KB) | Supplemental
  • 677 Views
  • 21 CrossRef citations
  • 0Altmetric
Article
Genomic and phenotypic characterization of nurse-like cells that promote drug resistance in chronic lymphocytic leukemia
Loic Ysebaert & Jean-Jacques Fournié
Pages: 1404-1406
Published online: 23 Jun 2011
AbstractforGenomic and phenotypic characterization of nurse-like cells that promote drug resistance in chronic lymphocytic leukemia | Full Text | References | PDF (459.6 KB)
  • 693 Views
  • 34 CrossRef citations
  • 0Altmetric
Article
Targeting the disturbed redox equilibrium in chronic lymphocytic leukemia by novel reactive oxygen species-catalytic ‘sensor/effector’ compounds
Nils Lilienthal, Christian Prinz, Abdul A. Peer-Zada, Mandy Doering, Lalla A. Ba, Michael Hallek, Claus Jacob & Marco Herling
Pages: 1407-1411
Published online: 29 Mar 2011
AbstractforTargeting the disturbed redox equilibrium in chronic lymphocytic leukemia by novel reactive oxygen species-catalytic ‘sensor/effector’ compounds | Full Text | References | PDF (864.3 KB) | Supplemental
  • 1086 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Direct and indirect costs for patients with myeloproliferative neoplasms
Jingbo Yu et al.
Article | Published online: 27 Apr 2024
Open Access
Targets and treatments in primary CNS lymphoma
Christina von Roemeling et al.
Review Article | Published online: 24 Apr 2024
Open Access
Challenges in management of older patients with chronic myeloid leukemia
Jessica M. Stempel et al.
Review Article | Published online: 23 Apr 2024
Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia
George Nesr et al.
Article | Published online: 23 Apr 2024
Open Access
View all latest articles